Literature DB >> 15515122

Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia.

Aysun Bay Karabulut1, Ayse Kafkasli, Feza Burak, Engin M Gozukara.   

Abstract

The aim of this study was to evaluate maternal-fetal plasma adenosine deaminase, xanthine oxidase (ADA, XO) activity and malondialdehyde (MDA) levels and the relationship between them in pre-eclampsia. Maternal and umbilical cord whole blood samples were taken from 29 pre-eclamptic and 33 normal pregnants. The plasma ADA, XO activities as well as MDA levels were assayed by spectrophotometric methods. MDA levels and ADA, XO activities were found to be higher in maternal and fetal plasma in pre-eclamptics than in normal pregnancy. The differences were statistically significant between groups (p < 0.05). Increased maternal-fetal plasma XO and ADA activities, as a marker of immunological disorder, may be related to the pathogenesis of pre-eclampsia. In addition, increased MDA levels may be a reflection of increased oxidative stress in pre-eclamptics and their fetuses. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15515122     DOI: 10.1002/cbf.1152

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  9 in total

Review 1.  Adenosine A₂a receptors and O₂ sensing in development.

Authors:  Brian J Koos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

2.  Serum uric acid levels associated with biochemical parameters linked to preeclampsia severity and to adverse perinatal outcomes.

Authors:  Elaine Luiza Santos Soares de Mendonça; João Victor Farias da Silva; Carolina Santos Mello; Alane Cabral Menezes de Oliveira
Journal:  Arch Gynecol Obstet       Date:  2022-01-07       Impact factor: 2.344

3.  Impaired A2A adenosine receptor/nitric oxide/VEGF signaling pathway in fetal endothelium during late- and early-onset preeclampsia.

Authors:  Carlos Escudero; Patricio Bertoglia; Myriam Hernadez; Cristian Celis; Marcelo Gonzalez; Claudio Aguayo; Jesenia Acurio
Journal:  Purinergic Signal       Date:  2012-11-21       Impact factor: 3.765

4.  Is Xanthine Oxidase, a Marker in Pre-eclampsia? A Case-Control Study.

Authors:  Vanishree Bambrana; C D Dayanand; Pushpa P Kotur
Journal:  J Clin Diagn Res       Date:  2015-10-01

5.  Increased xanthine oxidase in the skin of preeclamptic women.

Authors:  Shannon A Bainbridge; Jau-Shyong Deng; James M Roberts
Journal:  Reprod Sci       Date:  2009-02-05       Impact factor: 3.060

6.  Malondialdehyde and Antioxidant Enzymes in Maternal and Cord Blood, and their Correlation in Normotensive and Preeclamptic Women.

Authors:  Mohd Suhail; Safia Suhail; Bharat Kumar Gupta; Vinay Bharat
Journal:  J Clin Med Res       Date:  2009-08-12

7.  Changes in serum adenosine deaminase activity during normal pregnancy.

Authors:  Soo Jin Lee; Han Sung Hwang; Bit Na Rae Kim; Min A Kim; Jae Wook Lee; Yong Won Park; Young Han Kim
Journal:  J Korean Med Sci       Date:  2007-08       Impact factor: 2.153

8.  Plasma Adenosine Deaminase (ADA)-1 and -2 Demonstrate Robust Ontogeny Across the First Four Months of Human Life.

Authors:  Oludare A Odumade; Alec L Plotkin; Jensen Pak; Olubukola T Idoko; Matthew A Pettengill; Tobias R Kollmann; Al Ozonoff; Beate Kampmann; Ofer Levy; Kinga K Smolen
Journal:  Front Immunol       Date:  2021-05-27       Impact factor: 7.561

Review 9.  The Guanine-Based Purinergic System: The Tale of An Orphan Neuromodulation.

Authors:  Valentina Di Liberto; Giuseppa Mudò; Roberta Garozzo; Monica Frinchi; Víctor Fernandez-Dueñas; Patrizia Di Iorio; Renata Ciccarelli; Francesco Caciagli; Daniele F Condorelli; Francisco Ciruela; Natale Belluardo
Journal:  Front Pharmacol       Date:  2016-06-17       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.